Activin and Inhibin

FASN-IN-5 (example 11), a FASN inhibitor, can be used for the research of TH17- or CSF1 -mediated disease or disorder such as cancer , immunological disorders, and obesity.Form:Solid.

FATP1-IN-2 (compound 12a), an arylpiperazine derivative, is an orally active fatty acid transport protein 1 ( FATP1 ) inhibitor (human IC 50 =0.43 μM, mouse IC 50 =0.39 μM)In VivoFATP1-IN-2 (10 mg/kg: p.o.) shows a C max value above the mouse IC 50

FATP1-IN-2 (compound 12a), an arylpiperazine derivative, is an orally active fatty acid transport protein 1 ( FATP1 ) inhibitor (human IC 50 =0.43 μM, mouse IC 50 =0.39 μM)In VivoFATP1-IN-2 (10 mg/kg: p.o.) shows a C max value above the mouse IC 50

FATP1-IN-2 (compound 12a), an arylpiperazine derivative, is an orally active fatty acid transport protein 1 ( FATP1 ) inhibitor (human IC 50 =0.43 μM, mouse IC 50 =0.39 μM)In VivoFATP1-IN-2 (10 mg/kg: p.o.) shows a C max value above the mouse IC 50

FATP1-IN-2 (compound 12a), an arylpiperazine derivative, is an orally active fatty acid transport protein 1 ( FATP1 ) inhibitor (human IC 50 =0.43 μM, mouse IC 50 =0.39 μM)In VivoFATP1-IN-2 (10 mg/kg: p.o.) shows a C max value above the mouse IC 50

FCPR03 is a potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC 50 values of 60 nM, 31 nM and 47 nM for PDE4 catalytic domain , PDE4B1 and PDE4D7 , respectively. FCPR03 displays at least 2100-fold selectivity over other PDEs (PDE1-3

FCPR03 is a potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC 50 values of 60 nM, 31 nM and 47 nM for PDE4 catalytic domain , PDE4B1 and PDE4D7 , respectively. FCPR03 displays at least 2100-fold selectivity over other PDEs (PDE1-3

FCPR03 is a potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC 50 values of 60 nM, 31 nM and 47 nM for PDE4 catalytic domain , PDE4B1 and PDE4D7 , respectively. FCPR03 displays at least 2100-fold selectivity over other PDEs (PDE1-3

FCPR03 is a potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC 50 values of 60 nM, 31 nM and 47 nM for PDE4 catalytic domain , PDE4B1 and PDE4D7 , respectively. FCPR03 displays at least 2100-fold selectivity over other PDEs (PDE1-3

FCPR03 is a potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC 50 values of 60 nM, 31 nM and 47 nM for PDE4 catalytic domain , PDE4B1 and PDE4D7 , respectively. FCPR03 displays at least 2100-fold selectivity over other PDEs (PDE1-3

Febantel.

Febantel.